Impact of high neutrophil-to-lymphocyte ratio on survival in hospitalized cancer patients with COVID-19.

Díaz-Couselo FA, Flagel S, Nicolini C, Halac S, Manzano N, Aguirre M, Rébora J, Valle S, Noro L, Mohindroo C, McAllister F, Zylberman M

Open source

DOI
10.1002/cam4.5426
Published
2023 Mar
Container
Cancer medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cam4.5426,
  title = {Impact of high neutrophil-to-lymphocyte ratio on survival in hospitalized cancer patients with COVID-19.},
  author = {Díaz-Couselo FA and Flagel S and Nicolini C and Halac S and Manzano N and Aguirre M and Rébora J and Valle S and Noro L and Mohindroo C and McAllister F and Zylberman M},
  year = {2023},
  journal = {Cancer medicine},
  doi = {10.1002/cam4.5426},
  url = {https://doi.org/10.1002/cam4.5426}
}

RIS

TY  - JOUR
TI  - Impact of high neutrophil-to-lymphocyte ratio on survival in hospitalized cancer patients with COVID-19.
AU  - Díaz-Couselo FA
AU  - Flagel S
AU  - Nicolini C
AU  - Halac S
AU  - Manzano N
AU  - Aguirre M
AU  - Rébora J
AU  - Valle S
AU  - Noro L
AU  - Mohindroo C
AU  - McAllister F
AU  - Zylberman M
PY  - 2023
JO  - Cancer medicine
DO  - 10.1002/cam4.5426
UR  - https://doi.org/10.1002/cam4.5426
ER  - 

APA

FA, D., S, F., C, N., S, H., N, M., M, A., J, R., S, V., L, N., C, M., F, M., & M, Z. (2023). Impact of high neutrophil-to-lymphocyte ratio on survival in hospitalized cancer patients with COVID-19.. Cancer medicine. https://doi.org/10.1002/cam4.5426

Source records